We aimed to detect the validity of serum ATX as a diagnostic marker for liver fibrosis. Forty-eight males and 16 females were enrolled in the current study. Their ages ranged from 29-57 years with mean of 45.09, all were chronically HCV infected. Laboratory assessment was done for all subjects in form of complete blood picture; liver function test; lipid profile and serum detection of ATX. Patients were grouped according to the stage of fibrosis into group 1: fibrosis score 0, 1, 2, 3; group 2: fibrosis score: 4, 5, 6.The mean values of ATX in all studied patients with chronic HCV infection was 63.02 ± 36.29 while that of healthy controls was 65.31 ± 12.24 without any significant difference. Surprisingly, mean values of ATX were higher among patients with group 1 but it did not reach the significant level. In each group of them, the differences between mean values of ATX among different grades of liver fibrosis were insignificant. It was also noticed that the mean values of ATX were higher among men than in women .It was concluded that Autotoxin might not be used as a useful diagnostic marker for liver fibrosis in Egyptian chronic HCV patients.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Egyptian: Ministry of Health (El-Zanaty and Associates and Macro International, Cairo). 2009: :pp 431.
2. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the
3. Palmeri ML, Wang MH, Rouze NC, Abdelmalek MF, Guy CD, Moser B, et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. Journal of hepatology. 2011;55(3):666-72.
4. Boursier J, Isselin G, Fouchard-Hubert I, Oberti F, Dib N, Lebigot J, et al. Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. European journal of gastroenterology & hepatology. 2010;22(9):1074-84.
5. Ali Gaballa A.A.; Ayman M. Fouad; Mona I. Nabih; Halla M. Ragab and Nabila A. Abdalla. Vascular Endothelial growth factor expression in plasma of patients with liver cirrhosis and hepatocellular carcinoma. Kasr El Aini Medical Journal. 2003;9(6):361-370.
6. Mohab H. Halim., Nabila A. Abdalla, Halla M. Ragab, Nouran El Ghandour. Role of non invasive biomarkers in the assessment of liver condition in chronic hepatitis C Egyptian patients and if they correlate with the severity of liver affection. Med J Cairo Univ. 2005; 73( 4):49-62.
7. Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. BioEssays : news and reviews in molecular, cellular and developmental biology. 2004; 26 (8):870-81.
8. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.The Journal of biological chemistry. 1992;267(4):2524-9.
9. Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M, et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Molecular cancer. 2010;9:71.
10. Nakanaga K, Hama K, Aoki J. Autotaxin--an LPA producing enzyme with diverse functions. Journal of biochemistry. 2010;148(1):13-24.
11. Van Meeteren LA, Moolenaar WH. Regulation and biological activities of the autotaxin-LPA axis. Progress in lipid research. 2007;46(2):145-60.
12. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nature reviews Cancer. 2003;3(8):582-91.
13. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, et al. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life sciences. 2007;81(12):1009-15.
14. Winsten S, Cehelyk B. A rapid micro diazo technique for measuring total bilirubin. Clin Chim Acta. 1969; 25: 441-6.
15. Committee on enzymes of the Scandinavian Society for Clinical Chemistry and Clinical physiology. Recommended methods for the determination of four enzymes in blood. Scand J Lab Invest. 1974; 197(3): 291-299.
16. Butler JE, Spradling JE, Suter M, Dierks SE, Heyermann H, Peterman JH. The immunochemistry of sandwich ELISAs--I. The binding characteristics of immunoglobulins to monoclonal and polyclonal capture antibodies adsorbed on plastic and their detection by symmetrical and asymmetrical antibody-enzyme conjugates. Molecular immunology. 1986;23(9):971-82.
17. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. Journal of hepatology. 1995;22(6):696-9.
18. Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, Tateishi R, et al. Autotaxin as a novel serum marker of liver fibrosis.Clinica chimica acta; international journal of clinical chemistry. 2011;412(13-14):1201-6.
19. Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A, Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer letters. 2009;284(2):216-21.
20. Giganti A, Rodriguez M, Fould B, Moulharat N, Coge F, Chomarat P, et al. Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. The Journal of biological chemistry. 2008;283(12):7776-89.
21. Li S, Zhang J. Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells. Biochemical and biophysical research communications. 2009;378(2):264-8.
22. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogenactivated protein kinase: conservation of a three-kinase module from yeast to human. Physiological reviews. 1999;79(1):143-80.
23. Reeves HL, Dack CL, Peak M, Burt AD, Day CP. Stressactivated protein kinases in the activation of rat hepatic stellate cells in culture. Journal of hepatology. 2000;32(3):465-72.
24. Yu L, Sun X, Yang F, Yang J, Shen J, Wu Z. Inflammatory cytokines IFN-gamma, IL-4, IL-13 and TNF-alpha alterations in schistosomiasis: a meta-analysis. Parasitology research. 2012;110(4):1547-52.
25. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8(3):275-83.
26. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annual review of immunology. 1994;12:635-73.
27. Choi JW, Lee CW, Chun J. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochimica et biophysica acta. 2008;1781(9):531-9
28. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biological actions. Annual review of pharmacology and toxicology. 2010;50:157-86.
29. Nakamura K, Ohkawa R, Okubo S, Tozuka M, Okada M, Aoki S, et al. Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clinical biochemistry. 2007;40(3-4):274-7.
30. Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA : the journal of the American Medical Association. 2002;287(23):3081-2.
31. Li H, Wang D, Zhang H, Kirmani K, Zhao Z, Steinmetz R, et al.Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Molecular cancer therapeutics. 2009;8(6):1692-701.
33. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. The Journal of biological chemistry. 2002;277(42):39436-42.
34. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. The Journal of cell biology. 2002;158(2):227- 233.